Purchase the ATMP report at www.evernowpublishing.com

Subscribe to MedNous and get ahead in the business of medical innovation. Subscribe now.

The latest MedNous journal. Subscribe to download.

Schizophrenia compound progressed

Country: United Kingdom

Autifony Therapeutics Ltd has received funding to progress a second compound into clinical development that targets voltage-gated potassium channels in the brain. The indication is schizophrenia. It is already investigating a compound against the same target for hearing loss and tinnitus.

Read more

Horizon Discovery reports higher revenue

Country: United Kingdom

Horizon Discovery Group Plc, which provides services and products to the life science industry, reported a 79% increase in revenue to £11.9 million in 2014, a figure that includes income from two recent acquisitions.

Read more

New device for liver transplantation

Country: United Kingdom

Read more

How the brain processes pain

Country: Germany

Read more

IMI launches new Alzheimer’s project

Country: Belgium

Read more

Leukaemia’s resistance to radiation treatment overcome

Country: United States

Read more

Series B funding for Nabriva

Country: Austria

Read more

Japan follow-through on iPS

Country: Japan

Read more

UniQure in gene therapy deal with BMS

Country: Netherlands

Read more

Nicox had higher 2014 sales but wider loss

Country: France

Read more

Novartis in cancer pact with Aduro Biotech

Country: Switzerland

Read more

Looking for more?

Visit our news section for more articles.

News
Our full Mednous news archive
Appointments
Latest industry appointments
Events
A list of upcoming industry events

About Mednous

MedNous is a print publication and a website for everyone involved in medical research in Europe.

Read more

Free Article

How biopharma is exploiting the microbiome

MicrobiomeApr2015.pdf

Highlights of the April 2015 MedNous issue

The April 2015 MedNous features:

Latest Mednous cover
  • Business Strategy
    How biopharma is exploiting the microbiome
  • Health Technology Assessment
    Case study: Sovaldi is assessed in Europe
    By Karen Finn
  • Regenerative Medicine
    Diabetes findings exploited
  • Commentary
    Engineered cell therapies
    by Stefanos Theoharis
  • Stock Market Performance
    Success pushes European biotechs higher

The latest MedNous journal. Subscribe to download.